
CRISPR Breakthrough in Gene Editing Sparks a Biotech Investment Surge
A breakthrough in CRISPR gene therapy has triggered a surge in biotech investment, raising questions about access, regulation, and long-term viability...
Read Full Story →Explore our comprehensive coverage of gene editing, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

A breakthrough in CRISPR gene therapy has triggered a surge in biotech investment, raising questions about access, regulation, and long-term viability...
Read Full Story →
FashionThe 2026 convergence of the first Phase 3 in vivo CRISPR trial, FDA AI-enabled clinical trial optimi...
Medical ResearchA National Institutes of Health-funded team has engineered a compact CRISPR enzyme, Al3Cas12f, enabl...
Medical ResearchNIH-funded researchers have achieved a massive breakthrough by shrinking CRISPR 'molecular scissors'...
Medical ResearchIn a monumental June 2026 breakthrough, NIH scientists have successfully utilized CRISPR gene-editin...